The V-Set is a unique multi-lumen connector used to ensure the accuracy in the delivery of infusions and injections with no mixing of medications in the lines as they are independent from port to entry at cannula with no common space. This reduces the risk of drug interactions and adverse events, providing enhanced quality assurance and safety in the delivery of critical medications. In their article “Guidelines for the safe practice of total intravenous anaesthesia (TIVA), Nimmo et al recommend that during the delivery of TIVA, drug and fluid lines should join as close to the patient as possible to minimise dead space. Read the full article here - https://onlinelibrary.wiley.com/doi/full/10.1111/anae.14428 For more information visit our V-Set page - https://www.ltrmedical.com/v-set-device/
Immunoglobulin replacement therapy, first administered in the 1980's, has been the mainstay of treatment for primary and secondary immunodeficiencies. In the past, the most common treatment for immunoglobulin replacement was by intravenous infusion every 3-4 weeks. This is moving towards weekly subcutaneous immunoglobulin (SCIg) which can be self-administered by patients. The Springfusor is the ideal device to deliver SCIg, with the advantages including: No alarms No batteries No rate setting required Low pump cost Lightweight and portable Switching to self-administered SCIg has been shown to improve the quality of life and perceptions of general health in both adults and children, with improvements in pain and vitality and fewer days missed from school or work.
It was a pleasure to have Gilles Asselin from MedXL, Montreal, Canada visit us for the SHPA Medicines Management 2019 Conference on the Gold Coast this weekend, pictured here with Danny Zanardo, VP Commercial for LTR Medical